Health Economics, Policy and Law

2006 - 2025

From Cambridge University Press
Cambridge University Press, UPH, Shaftesbury Road, Cambridge CB2 8BS UK.
Bibliographic data for series maintained by Kirk Stebbing ().

Access Statistics for this journal.
Is something missing from the series or not right? See the RePEc data check for the archive and series.

Volume 4, issue 4, 2009

Should prospective payments be differentiated for public and private healthcare providers? pp. 383-403

Anne Mason, Andrew Street, Marisa Miraldo and Luigi Siciliani

Some pain, no gain: experiences with the no-claim rebate in the Dutch health care system pp. 405-424

J. Holland, Job van Exel, F.T. Schut and Werner Brouwer

Has the time come for cost-effectiveness analysis in US health care? pp. 425-443

Stirling Bryan, Shoshanna Sofaer, Taryn Siegelberg and Marthe Gold

Income and the use of health care: an empirical study of Egypt and Lebanon pp. 445-478

Heba Elgazzar

Choice and competition in publicly funded health care pp. 479-488

Julian Le Grand

The case against choice and competition pp. 489-501

David J. Hunter

Invisible hand? More like post-modern mush pp. 503-508

Jennifer Dixon

The rise of pragmatism in state/market debate pp. 509-511

Richard B. Saltman

Response to Hunter, Dixon and Saltman pp. 513-514

Julian Le Grand

Value based pricing for NHS medicines: magic bullet, counterfeit treatment or the mixture as before? pp. 515-526

David Taylor and Tina Craig

Choice experiments in health: the good, the bad, the ugly and toward a brighter future pp. 527-546

Jordan J. Louviere and Emily Lancsar

Volume 4, issue 3, 2009

Reforming medical governance in Europe. What is it about institutions? pp. 265-281

Viola Burau, David Wilsford and George France

Competition and compromise in negotiating the new governance of medical performance: the clinical governance and revalidation policies in the UK pp. 283-303

Laura Fenton and Brian Salter

The interplay between central and sub-central levels: the development of a systemic standard based programme for governing medical performance in Denmark pp. 305-327

Karsten Vrangbaek

The complexities of negotiating governance change: introducing managerialism in Italy pp. 329-346

Willem Tousijn and Vincenzo Mario Bruno Giorgino

Negotiating reform at an arm's length from the state: Disease Management Programmes and the introduction of clinical standards in Germany pp. 347-365

Viola Burau

Capacity and authority: comments on governing doctors and health care pp. 367-382

Joseph White

Volume 4, issue 2, 2009

Reimbursement systems, organisational forms and patient selection: Evidence from day surgery in Norway pp. 139-158

Pål E. Martinussen and Terje P. Hagen

Evaluating integrated healthcare for refugees and hosts in an African context pp. 159-178

Anais Tuepker and Chunhuei Chi

Access as a policy-relevant concept in low- and middle-income countries pp. 179-193

Di McIntyre, Michael Thiede and Stephen Birch

Access to health care services – an English policy perspective pp. 195-208

Maria Goddard

Is it not time for health economists to rethink equity and access? pp. 209-221

Gavin Mooney

Modernizing concepts of access and equity pp. 223-230

Martin Gulliford

Explicit incorporation of equity considerations into economic evaluation of public health interventions pp. 231-245

Richard Cookson, Mike Drummond and Helen Weatherly

Is the incorporation of equity considerations into economic evaluation really so simple? A comment on Cookson, Drummond and Weatherly pp. 247-254

Jeff Richardson

Still waiting for the great leap forward pp. 255-260

Alan Shiell

Explicit incorporation of equity considerations into economic evaluation of public health interventions – reply to Richardson and Shiell pp. 261-263

Richard Cookson, Mike Drummond and Helen Weatherly

Volume 4, issue 1, 2009

Patient choice and access to primary physician services in Norway pp. 11-27

Jostein Grytten and Rune J. Sørensen

Policy choice or economic fundamentals: what drives the public–private health expenditure balance in Canada? pp. 29-53

Livio Di Matteo

Small area variations and welfare loss in the use of outpatient antibiotics pp. 55-77

Massimo Filippini, Giuliano Masiero and Karine Moschetti

The legal framework for health care quality assurance in Germany pp. 79-98

Dirk Sauerland

Towards an alternative economics of health care pp. 99-114

Geoffrey Hodgson

Global health challenges in the pharmaceutical world pp. 115-127

John Abraham

Volume 3, issue 4, 2008

Social capital, economics, and health: new evidence pp. 321-331

Richard M. Scheffler and Timothy T. Brown

An economic model of social capital and health pp. 333-348

Sherman Folland

An exploratory study of associations between social capital and self-assessed health in Norway pp. 349-364

Tor Iversen

Access to psycho-social resources and health: exploratory findings from a survey of the French population pp. 365-391

Florence Jusot, Michel Grignon and Paul Dourgnon

Aging, social capital, and health care utilization in Canada pp. 393-411

Audrey Laporte, Eric Nauenberg and Leilei Shen

Social capital and the social formation of health-related preferences and behaviours pp. 413-427

Joan Costa-Font and Philipa Mladovsky

Volume 3, issue 3, 2008

Addressing legal and political barriers to global pharmaceutical access: Options for remedying the impact of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) and the imposition of TRIPS-plus standards pp. 229-256

Jillian Clare Cohen-Kohler, Lisa Forman and Nathaniel Lipkus

Willingness to pay for alternative policies for patients with Alzheimer’s Disease pp. 257-275

Miguel A. Negrín, Jaime Pinilla and Carmelo J. León

Valuing lives and life years: anomalies, implications, and an alternative pp. 277-300

Paul Dolan, Robert Metcalfe, Vicki Munro and Michael C. Christensen

Consumer-directed health care: promise or puffery? pp. 301-311

Daniel Callahan

Aid, truth, and policy: what do we know? pp. 313-319

Tony Barnett

Volume 3, issue 2, 2008

Nursing home performance in resident care in the United States: is it only a matter of for-profit versus not-for-profit? pp. 115-140

Frederic H. Decker

Public–Private Partnerships in the health sector: the Danish experience pp. 141-163

Vrangbæk*, Karsten

Aging, health expenditure, proximity to death, and income in Finland pp. 165-195

Unto Häkkinen, Pekka Martikainen, Anja Noro, Elina Nihtilä and Mikko Peltola

Systematic reviews – do they ‘work’ in informing decision-making around health inequalities? pp. 197-211

Mark Petticrew and Helen Roberts

Health economics made easy: guiding the initiated and uninitiated pp. 213-218

Charles Normand

Volume 3, issue 1, 2008

Defining hospital markets for antitrust enforcement: new approaches and their applicability to The Netherlands pp. 7-29

Marco Varkevisser, Cory S. Capps and Frederik T. Schut

Global public–private partnerships against neglected diseases: building governance structures for effective outcomes pp. 31-50

Sebastian Buckup

Prescription drug co-payments and cost-related medication underuse pp. 51-67

Todd H. Wagner, Michele Heisler and John D. Piette

Developing methods that really do value the ‘Q’ in the QALY pp. 69-77

Paul Dolan

Valuing health properly pp. 79-83

Daniel M. Hausman

Are subjective well-being measures any better than decision utility measures? pp. 85-91

Dylan M. Smith, Stephanie L. Brown and Peter A. Ubel

In defence of subjective well-being pp. 93-95

Paul Dolan

Shaping the future of humankind: three commentaries on the ethics of enhancement pp. 97-105

Robert Dingwall